Cargando…
Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression
Developments of non-viral carriers have headed toward reducing cytotoxicity, which results from the use of conventional gene carriers, and enhancing gene delivery efficiency. Cys-(d-R9)-Cys repeated reducible poly(oligo-D-arginine) (rPOA) is one of the most efficient non-viral carriers for gene ther...
Autores principales: | Woo, Jongsu, Bae, Seong-Ho, Kim, Bokyoung, Park, Jin Sil, Jung, Subin, Lee, Minhyung, Kim, Yong-Hee, Choi, Donghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674056/ https://www.ncbi.nlm.nih.gov/pubmed/26649571 http://dx.doi.org/10.1371/journal.pone.0144491 |
Ejemplares similares
-
Poly(ethylene glycol)-Based Peptidomimetic “PEGtide”
of Oligo-Arginine Allows for Efficient siRNA Transfection and Gene
Inhibition
por: Hibbitts, Alan, et al.
Publicado: (2019) -
Therapeutic effects of a mesenchymal stem cell-based insulin-like growth factor-1/enhanced green fluorescent protein dual gene sorting system in a myocardial infarction rat model
por: Jung, Subin, et al.
Publicado: (2018) -
Click to enter: activation of oligo-arginine cell-penetrating peptides by bioorthogonal tetrazine ligations
por: Bode, Saskia A., et al.
Publicado: (2018) -
Arginine and Endothelial Function
por: Gambardella, Jessica, et al.
Publicado: (2020) -
Hydrophilization of Poly(Caprolactone) Copolymers through Introduction of Oligo(Ethylene Glycol) Moieties
por: Wurth, Jonathan J., et al.
Publicado: (2014)